Showing results (251-260 of 271) with videos related to
Sort By:
Pageof 28
Cell|January 24, 2012
Mutant p53 disrupts mammary tissue architecture via the mevalonate pathwayWilliam A Freed-Pastor, Hideaki Mizuno, Xi Zhao, et al.Nature Communications|May 19, 2022
Different hotspot p53 mutants exert distinct phenotypes and predict outcome of colorectal cancer patientsOri Hassin, Nishanth Belugali Nataraj, Michal Shreberk-Shaked, et al.The Journal of Clinical Investigation|August 29, 2017
Dysfunction of the MDM2/p53 axis is linked to premature agingDavor Lessel, Danyi Wu, Carlos Trujillo, et al.Proceedings of the National Academy of Sciences of the United States of America|April 19, 2022
Cross-talk between mutant p53 and p62/SQSTM1 augments cancer cell migration by promoting the degradation of cell adhesion proteinsSaptaparna Mukherjee, Martino Maddalena, YiQing Lü, et al.Scientific Reports|July 2, 2016
Capturing tumor complexity in vitro: Comparative analysis of 2D and 3D tumor models for drug discoveryKristin Stock, Marta F Estrada, Suzana Vidic, et al.Cell Reports|May 26, 2021
PD-L1 recruits phospholipase C and enhances tumorigenicity of lung tumors harboring mutant forms of EGFRSoma Ghosh, Nishanth Belugali Nataraj, Ashish Noronha, et al.Proceedings of the National Academy of Sciences of the United States of America|December 21, 2023
p53 deficient breast cancer cells reprogram preadipocytes toward tumor-protective immunomodulatory cellsOri Hassin, Miriam Sernik, Adi Seligman, et al.Cell|December 25, 2018
p53 Represses the Mevalonate Pathway to Mediate Tumor SuppressionSung-Hwan Moon, Chun-Hao Huang, Shauna L Houlihan, et al.Molecular Cell|March 3, 2011
Requirement of ATM-dependent monoubiquitylation of histone H2B for timely repair of DNA double-strand breaksLilach Moyal, Yaniv Lerenthal, Mali Gana-Weisz, et al.Cell|August 28, 2018
Small Molecules Co-targeting CKIα and the Transcriptional Kinases CDK7/9 Control AML in Preclinical ModelsWaleed Minzel, Avanthika Venkatachalam, Avner Fink, et al.Pageof 28